In Vivo Tumor Grading of Prostate Cancer Using Quantitative 111In-Capromab Pendetide SPECT/CT
暂无分享,去创建一个
Youngho Seo | Carina Mari Aparici | Badrinath R Konety | Matthew R Cooperberg | M. Cooperberg | Youngho Seo | R. Hawkins | B. Konety | C. Aparici | Randall A Hawkins
[1] Lennart Franzén,et al. How well does the Gleason score predict prostate cancer death? A 20-year followup of a population based cohort in Sweden. , 2006, The Journal of urology.
[2] M. Bandstra,et al. Measurements of Fukushima fallout by the Berkeley Radiological Air and Water Monitoring project , 2011, 2011 IEEE Nuclear Science Symposium Conference Record.
[3] J. Kurhanewicz,et al. Magnetic Resonance Imaging and Spectroscopic Imaging of Prostate Cancer , 2001, Cancer investigation.
[4] Kenneth H. Wong,et al. Progress in SPECT/CT Imaging of Prostate Cancer , 2006, Technology in cancer research & treatment.
[5] B. Leibovich,et al. Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival. , 2006, The Journal of urology.
[6] M. Kattan,et al. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. , 2005, Radiology.
[7] Martin G Pomper,et al. Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer. , 2009, Cancer research.
[8] Anna Celler,et al. Implementation of an iterative scatter correction, the influence of attenuation map quality and their effect on absolute quantitation in SPECT , 2007, Physics in medicine and biology.
[9] J R Perry,et al. Correction of nonuniform attenuation in cardiac SPECT imaging. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] Kenneth H. Wong,et al. Calculation and validation of the use of effective attenuation coefficient for attenuation correction in In-111 SPECT. , 2005, Medical physics.
[11] S C Huang,et al. Anatomy of SUV. Standardized uptake value. , 2000, Nuclear medicine and biology.
[12] Sung-Cheng Huang,et al. Anatomy of SUV , 2000 .
[13] Floris P Jansen,et al. The future of SPECT in a time of PET. , 2007, Nuclear medicine and biology.
[14] Ernest V. Garcia,et al. Spect attenuation correction: an essential tool to realize nuclear cardiology’s manifest destiny , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[15] Youngho Seo,et al. Technological development and advances in single-photon emission computed tomography/computed tomography. , 2008, Seminars in nuclear medicine.
[16] Mingshan Sun,et al. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] M. Manyak,et al. Indium-111 capromab pendetide in the management of recurrent prostate cancer , 2008, Expert review of anticancer therapy.
[18] Michael Lassmann,et al. The impact of PET and SPECT on dosimetry for targeted radionuclide therapy. , 2006, Zeitschrift fur medizinische Physik.
[19] Zheng Chang,et al. Problems created in attenuation-corrected SPECT images by artifacts in attenuation maps: a simulation study. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] S. Campbell,et al. Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer. , 2007, International journal of radiation oncology, biology, physics.
[21] I. Buvat,et al. Partial-Volume Effect in PET Tumor Imaging* , 2007, Journal of Nuclear Medicine.
[22] D. Gleason,et al. Histologic grading of prostate cancer: a perspective. , 1992, Human pathology.
[23] A. Markham,et al. Prostate-specific membrane antigen , 2017, Radiopaedia.org.
[24] D. Bostwick,et al. Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. , 1998, Urology.
[25] S. Libutti,et al. Partial-Volume Correction in PET: Validation of an Iterative Postreconstruction Method with Phantom and Patient Data , 2007, Journal of Nuclear Medicine.
[26] W P Segars,et al. Fast modelling of the collimator–detector response in Monte Carlo simulation of SPECT imaging using the angular response function , 2005, Physics in medicine and biology.